TY  - GEN
AU  - Okines,A F C
AU  - Thompson,L C
AU  - Cunningham,D
AU  - Wotherspoon,A
AU  - Reis-Filho,J S
AU  - Langley,R E
AU  - Waddell,T S
AU  - Noor,D
AU  - Eltahir,Z
AU  - Wong,R
AU  - Stenning,S
TI  - Effect of HER2 on prognosis and benefit from peri-operative chemotherapy in early oesophago-gastric adenocarcinoma in the MAGIC trial
SN  - 1569-8041
PY  - 2013///1219
KW  - Adenocarcinoma
KW  - drug therapy
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Agents
KW  - therapeutic use
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - administration & dosage
KW  - Biomarkers, Tumor
KW  - metabolism
KW  - Cisplatin
KW  - Combined Modality Therapy
KW  - Epirubicin
KW  - Esophageal Neoplasms
KW  - Female
KW  - Fluorouracil
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Perioperative Period
KW  - Prognosis
KW  - Receptor, ErbB-2
KW  - genetics
KW  - Stomach Neoplasms
KW  - Young Adult
N1  - Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1093/annonc/mds622
ER  -